scholarly journals Mutagenic activation and detoxification of benzo[a]pyrene in vitro by hepatic cytochrome P450 1A1 and phase II enzymes in three meat-producing animals

2010 ◽  
Vol 48 (8-9) ◽  
pp. 2526-2531 ◽  
Author(s):  
W. Darwish ◽  
Y. Ikenaka ◽  
E. Eldaly ◽  
M. Ishizuka
2012 ◽  
Vol 108 (12) ◽  
pp. 2158-2165 ◽  
Author(s):  
Eliz Warwick ◽  
Aedín Cassidy ◽  
Bryan Hanley ◽  
Zeina E. Jouni ◽  
Yongping Bao

Phase II metabolising enzymes enable the metabolism and excretion of potentially harmful substances in adults, but to date it is unclear whether dietary phytochemicals can induce phase II enzymes differently between adults and infants. We investigated the expression of phase II enzymes in an in vitro model of primary skin fibroblasts at three different developmental stages, 1 month, 2 years and adult, to examine potential differences in age-related phase II enzymes in response to different phytochemicals (5–20 μm) including sulphoraphane, quercetin and catechin. Following phytochemical treatment, a significant increase in mRNA of glutathione S-transferase A1 (GSTA1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) was observed, with the most marked increases seen in response to sulphoraphane (3–10-fold for GSTA1, P = 0·001, and 6–35-fold for NQO1, P = 0·001–0·017). Catechin also induced 3–5-fold changes in NQO1 transcription, whereas quercetin had less effect on NQO1 mRNA induction in infant cells. Moreover, NQO1 protein levels were significantly increased in 2-year-old and adult cell models in response to sulphoraphane treatment. These results suggest that metabolic plasticity and response to xenobiotics may be different in infants and adults; and therefore the inclusion of phytochemicals in the infant diet may modulate their induction of phase II metabolism, thereby providing increased protection from potentially harmful xenobiotics in later life.


2005 ◽  
Vol 27 (4) ◽  
pp. 803-810 ◽  
Author(s):  
Jianjun Gao ◽  
Khosrow Kashfi ◽  
Xiaoping Liu ◽  
Basil Rigas
Keyword(s):  
Phase Ii ◽  

2015 ◽  
Vol 168 ◽  
pp. 146-149 ◽  
Author(s):  
Chong-Zhen Qin ◽  
Qiao-Li Lv ◽  
Na-Yiyuan Wu ◽  
Lin Cheng ◽  
Yun-Chen Chu ◽  
...  

1998 ◽  
Vol 157 (1) ◽  
pp. 63-70 ◽  
Author(s):  
JM Wilson ◽  
MM Vijayan ◽  
CJ Kennedy ◽  
GK Iwama ◽  
TW Moon

We report for the first time that beta-naphthoflavone (BNF) abolishes ACTH stimulation of cortisol production in rainbow trout (Oncorhynchus mykiss). There was significantly higher hepatic cytochrome P450 content and ethoxyresorufin O-de-ethylase and uridine-5'-diphosphoglucuronic acid transferase activities in BNF-treated fish than in sham-treated controls. BNF did not significantly affect either plasma turnover or tissue distribution of [3H]cortisol-derived radioactivity. Hepatic membrane fluidity and hepatocyte capacity for cortisol uptake were not altered by BNF as compared with the sham-treated fish. These results taken together suggest that BNF does not affect cortisol-clearance mechanisms in trout. A 3 min handling disturbance period elicited a plasma cortisol response in the sham-treated fish; however, the response in the BNF-treated fish was muted and significantly lower than in the sham fish. This in vivo response corroborates the lack of interrenal sensitivity to ACTH in vitro in the BNF-treated fish, suggesting that BNF affects the ACTH pathway in trout. Our results suggest the possibility that cytochrome P450-inducing compounds may affect cortisol dynamics by decreasing interrenal responsiveness to ACTH stimulation in fish, thereby impairing the physiological responses that are necessary for the animal to cope with the stressor.


2013 ◽  
Vol 266 (3) ◽  
pp. 419-429 ◽  
Author(s):  
Issa E.A. Amara ◽  
Anwar Anwar-Mohamed ◽  
Ghada Abdelhamid ◽  
Ayman O.S. El-Kadi

1992 ◽  
Vol 43 (7) ◽  
pp. 1439-1447 ◽  
Author(s):  
H.M. Wortelboer ◽  
C.A. De Kruif ◽  
A.A.J. Van Iersel ◽  
H.E. Falke ◽  
J. Noordhoek ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document